[163386] in SIPB-AFS-requests
Bonus-No.165627861992 - Please-Redeem Your CVS-Points Now.
daemon@ATHENA.MIT.EDU (CVSPoints)
Thu Mar 9 14:50:18 2017
From KathleenJeffries@points.yourrewardsnewestpoints.com Thu Mar 09 19:50:17 2017
Return-Path: <KathleenJeffries@points.yourrewardsnewestpoints.com>
Delivered-To: sipb-afsreq-mtg@charon.mit.edu
Received: (qmail 16460 invoked from network); 9 Mar 2017 19:50:17 -0000
Received: from ih426584.dedic.myihor.ru (HELO points.yourrewardsnewestpoints.com) (194.67.222.15)
by charon.mit.edu with SMTP; 9 Mar 2017 19:50:17 -0000
Date: Thu, 09 Mar 2017 12:51:02 -0700
From: CVSPoints <CVSPoints@yourrewardsnewestpoints.com>
Message-ID: <dg82.d898335678161g21-8dy16562786dg2_d7yhg2@mail.yourrewardsnewestpoints.com>
Subject: Bonus-No.165627861992 - Please-Redeem Your CVS-Points Now.
Content-Type: text/html; charset=UTF-8
MIME-Version: 1.0
Content-transfer-encoding: 8bit
To: sipb-afsreq-mtg@charon.mit.edu
Priority: Normal
Reply-To: CVSPoints@yourrewardsnewestpoints.com
<html>
<head>
<title>Bonus-Updates</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<style type="text/css">
#bg28jd {
font-family: Verdana, Geneva, sans-serif;
font-size: 7.8px;
}
#uiwueh8 {
font-family: Verdana, Geneva, sans-serif;
font-size: 14.5px;
text-align: center;
}
#xkbwu3 {
font-family: Verdana, Geneva, sans-serif;
font-size: 14px;
}
#xwihu29sk {
font-family: Verdana, Geneva, sans-serif;
font-size: 14px;
}
</style>
</head>
<body bgcolor="#FFFFFF" leftmargin="0" topmargin="0" marginwidth="0" marginheight="0">
<table id="Table_01" width="593" height="584" border="0" cellpadding="0" cellspacing="0">
<tr>
<td>
<center><a href="http://newbonus.yourrewardsnewestpoints.com"><img src="http://see1.yourrewardsnewestpoints.com" width="215" height="172" alt=""></a></center></td>
</tr>
<tr>
<td id="xkbwu3">Hello sipb-afsreq-mtg@charon.mit.edu,<br></td>
</tr>
<tr>
<td id="uiwueh8"><p><br>
Alert: Your CVS Bonus-Points are Going to Expire-Soon!</p>
<p>Are you-aware that you have $50-in CVS-Points available? These bonus-points are going to-expire within the next 48-hours if you have not-redeemed them.</p>
<p>This reward is a "thank you" for being such a loyal customer; all we ask in return is that you fill-out the short-survey provided so we can make sure that all of our customers are satisfied.</p>
<p><br>
<span style="font-weight: bold"><a href="http://newbonus.yourrewardsnewestpoints.com">Go Here to Receive Your $50-CVS Bonus-Now</a></span></p></td>
</tr>
<tr>
<td id="xwihu29sk"><p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
<p>If you'd rather-quit receiving these-bonusads-please visit-right <a href="http://nytr4.yourrewardsnewestpoints.com">here</a>.<br>
#_-2885 SANF0RD-AVENUE S.W. #40442,Grandville, M.l. #49418.</p>
<p> </p></td>
</tr>
<tr>
<td id="bg28jd"><p> </p>
<p> </p>
<p>Upside for CVS Stock? CVS Health Corp (NYSE:CVS) stock operates in the consumer staples sector of the market. Consumer staples are products that are required by consumers, not matter how the economy is performing. Therefore, foot traffic and sales should remain steady, if not increase. This also has a lot to do with the company’s market segment. CVS Health Corp is a healthcare provider that operates in three different segments: pharmacy services, retail, and corporate services. The healthcare segment can appear boring from an investment point of view, but there are a few positive catalysts to look forward to. Let me explain.<br>
Positive Catalysts The first positive catalyst is an increase in CVS’ store count via an acquisition of pharmacies located within Target Corporation (NYSE:TGT) stores. This has given the company access to new customers and another method to drive up sales. From an investor’s point of view, this move could be seen as risky. That’s because of the chance of a decrease in Target’s foot traffic; would it impact CVS’ sales? However, when looking at the big picture, this is a non-issue for CVS. This is because the pharmacy business will always continue to see sales, as consumers will always need their medicine. Another key driver for CVS stock is its “ScriptSync” service, launched in 2015. This is a service that works around a patient’s schedule when they need to pick up a prescription. This services helps to ensure a customer’s brand loyalty and also contributes to the previously mentioned foot traffic. In addition, increased foot traffic means there is a possibility of increasing the average transaction, since customers could become more likely to pick up other items while there. Something for investors to look forward to is the changing U.S. population. A rise in the number of American seniors should also mean an increase in demand for CVS’ locations and products. After all, a more aged population needs more people with a regular need for medication.</p>
<p>CVS stock pays a dividend of $0.50 per share, with the amount having risen by 16% just a few weeks ago. But this was not the first time the dividend had seen a hike, having increased for the past eight years. The shares offer a current yield of 2.53%, trading at $79.00. Another method management has used to return money to shareholders is share repurchase programs. The current program is for $3.7 billion shares and, once completed, a recently authorized $15.0-billion buyback program will begin. When comparing the total from share programs to the total market cap of the company, this would represent 22%, which is quite impressive. (Source: “CVS Health Reports Third Quarter Results,” CVS Health Corp, November 8, 2016.)<br>
Final Thoughts on CVS Stock Shares of CVS stock are down 19% over the past year, which isn’t great news for current investors. However, it’s still worth considering owning CVS stock or adding it to one’s position, with the current dividend yield being higher now due to a lower stock price. There is also a possibility of more dividend hikes and share purchases being authorized, given that the current payout ratio is 35%. CVS stock has everything it needs for growth to continue to reward the shareholder base. What CVS Health knows about prescriptions could fill a few Target superstores. And what Target owns in real estate could remedy many of CVS’ expansion issues. So like bacon and doughnuts, they’ve made what at first seemed an unlikely pairing – until you think about it. As the analysts have made clear, Target’s agreement to sell its pharmacies to CVS Health can resolve several competitive challenges for both brands. That said, they’ll each need to take analytical precautions to avoid certain side effects. Essential to the partnership working is its ability to mutually benefit both companies, and achieving that balance will take much work rolling forward. No doubt the advantages are there on face: Transitioning the pharmacy brand from Target to CVS enhances the opportunity to attract more customers and foot traffic through Target stores, while unloading what is for Target a highly regulated distraction. Target’s pharmacy business generates less than 5 percent of its nearly $73 billion in revenue, according to a report in Forbes. Prescription drugs at the $140 billion CVS, meanwhile, represent almost 71 percent of revenue. However, such efficiencies, not to mention the power of the two brands’ halo effect, do not on their own guarantee a sustained mutual gain. For that, a series of data sets would serve well to evaluate the full nature of any business combination. In the case of CVS and Target, I’d suggest three key data sets to start: Location, location, relations: The first logical consideration for both retailers would be whether the 1,600 Target locations are highly complementary to the CVS network. To be sure, Target would carry CVS into new markets, particularly in the Northwest, but location opportunities extend beyond physical geography. Rather, a location’s worth hinges on the brand’s ability to engage with that immediate customer base through culture, values or basic needs.</p>
<p> </p>
<p> </p></td>
</tr>
</table>
<img src="http://trc.yourrewardsnewestpoints.com/redirect.php?email=sipb-afsreq-mtg@charon.mit.edu">
</body>
</html>
